These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18020970)

  • 1. Hyperhomocysteinemia and high-density lipoprotein metabolism in cardiovascular disease.
    Liao D; Yang X; Wang H
    Clin Chem Lab Med; 2007; 45(12):1652-9. PubMed ID: 18020970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-I Protein synthesis and enhancing HDL cholesterol clearance.
    Liao D; Tan H; Hui R; Li Z; Jiang X; Gaubatz J; Yang F; Durante W; Chan L; Schafer AI; Pownall HJ; Yang X; Wang H
    Circ Res; 2006 Sep; 99(6):598-606. PubMed ID: 16931800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated homocysteine reduces apolipoprotein A-I expression in hyperhomocysteinemic mice and in males with coronary artery disease.
    Mikael LG; Genest J; Rozen R
    Circ Res; 2006 Mar; 98(4):564-71. PubMed ID: 16439690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homocysteine diminishes apolipoprotein A-I function and expression in patients with hypothyroidism: a cross-sectional study.
    Yang N; Yao Z; Miao L; Liu J; Gao X; Xu Y; Wang G
    Lipids Health Dis; 2016 Jul; 15():123. PubMed ID: 27457726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperhomocysteinemia is associated with decreased apolipoprotein AI levels in normal healthy people.
    Wang Y; Liu J; Jiang Y; Zhang H; Leng S; Wang G
    BMC Cardiovasc Disord; 2016 Jan; 16():10. PubMed ID: 26758372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal lipid metabolism in cystathionine beta-synthase-deficient mice, an animal model for hyperhomocysteinemia.
    Namekata K; Enokido Y; Ishii I; Nagai Y; Harada T; Kimura H
    J Biol Chem; 2004 Dec; 279(51):52961-9. PubMed ID: 15466479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperhomocysteinemia accelerates atherosclerosis in cystathionine beta-synthase and apolipoprotein E double knock-out mice with and without dietary perturbation.
    Wang H; Jiang X; Yang F; Gaubatz JW; Ma L; Magera MJ; Yang X; Berger PB; Durante W; Pownall HJ; Schafer AI
    Blood; 2003 May; 101(10):3901-7. PubMed ID: 12506016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperhomocysteinemia and atherosclerosis.
    Yang F; Tan HM; Wang H
    Sheng Li Xue Bao; 2005 Apr; 57(2):103-14. PubMed ID: 15830093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperhomocysteinemia is associated with hypertriglyceridemia in mice with methylenetetrahydrofolate reductase deficiency.
    Mikael LG; Wang XL; Wu Q; Jiang H; Maclean KN; Rozen R
    Mol Genet Metab; 2009; 98(1-2):187-94. PubMed ID: 19560954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperhomocysteinemia induces hepatic cholesterol biosynthesis and lipid accumulation via activation of transcription factors.
    Woo CW; Siow YL; Pierce GN; Choy PC; Minuk GY; Mymin D; O K
    Am J Physiol Endocrinol Metab; 2005 May; 288(5):E1002-10. PubMed ID: 15644462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of myeloperoxidase oxidation and
    Kameda T; Horiuchi Y; Shimano S; Yano K; Lai SJ; Ichimura N; Tohda S; Kurihara Y; Tozuka M; Ohkawa R
    Biol Chem; 2022 Feb; 403(3):265-277. PubMed ID: 34448387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pioglitazone stimulates apolipoprotein A-I production without affecting HDL removal in HepG2 cells: involvement of PPAR-alpha.
    Qin S; Liu T; Kamanna VS; Kashyap ML
    Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2428-34. PubMed ID: 17872455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ApoA-I: a missing link between homocysteine and lipid metabolism?
    Devlin AM; Lentz SR
    Circ Res; 2006 Mar; 98(4):431-3. PubMed ID: 16514070
    [No Abstract]   [Full Text] [Related]  

  • 14. Hyperhomocysteinemia: a biochemical link between bone and cardiovascular system diseases?
    Petramala L; Acca M; Francucci CM; D'Erasmo E
    J Endocrinol Invest; 2009; 32(4 Suppl):10-4. PubMed ID: 19724160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homocysteine facilitates LOX-1 activation and endothelial death through the PKCβ and SIRT1/HSF1 mechanism: relevance to human hyperhomocysteinaemia.
    Hung CH; Chan SH; Chu PM; Tsai KL
    Clin Sci (Lond); 2015 Sep; 129(6):477-87. PubMed ID: 25982096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Alterations in the protein content and dysfunction of high-density lipoproteins from hyperhomocysteinemic mice].
    Julve J; Errico TL; Chen X; Santos D; Freixa J; Porcel I; Cubero E; Escolà-Gil JC; Blanco-Vaca F
    Clin Investig Arterioscler; 2013; 25(4):164-73. PubMed ID: 23938051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A selective peroxisome proliferator-activated receptor δ agonist PYPEP suppresses atherosclerosis in association with improvement of the serum lipoprotein profiles in human apolipoprotein B100 and cholesteryl ester transfer protein double transgenic mice.
    Naya N; Fukao K; Nakamura A; Hamada T; Sugimoto M; Kojima M; Yoshimura N; Uwabe K; Imagawa K; Nomura K; Hara S; Nakano T; Iwasaki T; Shinosaki T; Hanasaki K
    Metabolism; 2016 Jan; 65(1):16-25. PubMed ID: 26683793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease.
    Jakubowski H
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 9():155-67. PubMed ID: 19261978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase.
    Yuhanna IS; Zhu Y; Cox BE; Hahner LD; Osborne-Lawrence S; Lu P; Marcel YL; Anderson RG; Mendelsohn ME; Hobbs HH; Shaul PW
    Nat Med; 2001 Jul; 7(7):853-7. PubMed ID: 11433352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homocysteine modulates the effect of simvastatin on expression of ApoA-I and NF-kappaB/iNOS.
    Mikael LG; Rozen R
    Cardiovasc Res; 2008 Oct; 80(1):151-8. PubMed ID: 18540024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.